Novate receives €4m in funding
The financing was co-led by Dublin based ACT Venture Capital and life science investor Seroba BioVentures, with Enterprise Ireland also participating in the round.
Novate was formed in 2006 to develop and commercialise a novel technology aimed at the rapidly expanding market for inferior vena cava filters.

 
			     
                     
                     
                     
  
  
  
  
  
 



 
          

